2026-05-15T09:28:27-05:00 2025-06-30 411360831 OLSEN THIELEN & CO LTD 2675 LONG LAKE ROAD ST PAUL MN 55113 990 2025-01-01 411893645 CHILDREN'S CANCER RESEARCH FUND CHIL 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 ELIZABETH ALLEN CHIEF EXECUTIVE OFFICER 9528939355 2026-05-14 1 RYAN VETTRUS CPA P01243596 6514834521 2025 2025-03-06 01:10:19Z ELIZABETH ALLEN 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 8552334 0 X WWW.CHILDRENSCANCER.ORG X 1997 MN CHILDREN'S CANCER RESEARCH FUND FUELS TRANSFORMATIONAL RESEARCH TO BRING BETTER TREATMENTS AND CURES TO CHILDREN WITH CANCER. 15 14 0 70 0 0 18237103 3312780 0 0 865489 1352490 -198696 -194863 18903896 4470407 5676081 2971846 0 0 4169739 2273265 0 0 907987 8066765 2001142 17912585 7246253 991311 -2775846 17538090 11242965 10004026 7718147 7534064 3524818 X CHILDREN'S CANCER RESEARCH FUND FUELS TRANSFORMATIONAL RESEARCH TO BRING BETTER TREATMENTS AND CURES TO CHILDREN WITH CANCER. 0 0 3328555 2971846 RESEARCH AND GRANTING PROGRAMS:IN FY25, CCRF AWARDED NEARLY $2.3 MILLION IN RESEARCH GRANTS IN THE FOLLOWING AREAS: - HARD-TO-TREAT CANCERS: CCRF PRIORITIZES RESEARCH ON CANCERS WITH PERSISTENTLY LOW SURVIVAL RATES. THESE INCLUDE HIGHLY AGGRESSIVE AND OFTEN FATAL CANCERS SUCH AS BRAIN TUMORS, SARCOMAS, AND CERTAIN TYPES OF LEUKEMIA. IN FY25, WE AWARDED $250,000 TO FUND A PROJECT AT MD ANDERSEN CANCER CENTER TESTING A NOVEL DRUG CANDIDATE THAT TARGETS A KEY DRIVER OF ACUTE MYELOID LEUKEMIA (AML). WE ALSO AWARDED $187,799 TO A RESEARCHER AT THE UNIVERSITY OF MINNESOTA WHO IS WORKING ON NEW TREATMENTS ENABLING IMMUNE CELLS TO BETTER INFILTRATE HIGH-RISK BRAIN TUMORS, INCLUDING DIFFUSE MIDLINE GLIOMA AND GLIOBLASTOMA. IF SUCCESSFUL, THIS RESEARCH WOULD FURTHER IMPROVE THE EFFICACY OF A NOVEL IMMUNOTHERAPY DEVELOPED BY UNIVERSITY OF MINNESOTA RESEARCHERS WITH CCRF SUPPORT. FINALLY, WE AWARDED $375,000 TO THE UNIVERSITY OF MINNESOTA IN SEED GRANTS FOR RESEARCH INITIATIVES, ALLOWING FLEXIBLE AND NIMBLE FUNDING FOR EMERGING OPPORTUNITIES. - SURVIVORSHIP: MANY CHILDHOOD CANCER SURVIVORS LIVE WITH ENDURING CONSEQUENCES OF CHEMOTHERAPY, RADIATION, OR SURGICAL INTERVENTIONS, INCLUDING COGNITIVE IMPAIRMENT, CARDIAC ISSUES AND INFERTILITY. CCRF SUPPORTS RESEARCHERS WORKING ON NEW TREATMENTS AND INTERVENTIONS THAT WILL REDUCE ADVERSE LONG-TERM EFFECTS AND PROMOTE HEALTH AMONG SURVIVORS. IN FY25, CCRF GRANTED $250,000 TO A RESEARCHER AT CHILDREN'S HOSPITAL OF PHILADELPHIA TO CONDUCT A RANDOMIZED TRIAL OF A GAME-LIKE TECHNOLOGY AIMED AT HELPING BRAIN TUMOR SURVIVORS BETTER UNDERSTAND FACIAL CUES AND BUILD CRITICAL SOCIAL CONNECTIONS. - FELLOWSHIPS: CCRF MADE A COMMITMENT OF $1.2 MILLION IN FY25 TO SUPPORT THE CHILDREN'S CANCER RESEARCH FUND PEDIATRIC ONCOLOGY/HEMATOLOGY FELLOWSHIP PROGRAM AT THE UNIVERSITY OF MINNESOTA. THIS COMMITMENT BUILDS ON NEARLY 40 YEARS OF SUPPORT FOR RESEARCH FELLOWSHIPS AT THE UNIVERSITY OF MINNESOTA, A PROGRAM WITH A STRONG LEGACY OF TRAINING EXCEPTIONAL LEADERS IN PEDIATRIC CANCER CARE AND RESEARCH. 1816871 EDUCATION AND AWARENESS PROGRAM:IN ADDITION TO FUNDING RESEARCH AND OFFERING SUPPORT PROGRAMS, WE GENERATE AWARENESS ABOUT THE NEED FOR CHILDHOOD CANCER RESEARCH AND PROVIDE EDUCATIONAL RESOURCES FOR RESEARCHERS. WE REACH MILLIONS OF PEOPLE THROUGH OUR WEBSITE, DIGITAL AND SOCIAL MEDIA PLATFORMS, AND IN-KIND TELEVISION AND PRINT ADVERTISING TO SHARE THE STORIES OF KIDS, FAMILIES, AND RESEARCHERS. WE'RE ALSO PROUD TO SUPPORT THE CANCER SURVIVORSHIP CONFERENCE, THE MARK E. NESBIT LECTURESHIP IN PEDIATRIC ONCOLOGY, AND THE NORMA K.C. RAMSAY, MD, DISTINGUISHED VISITING PROFESSOR LECTURESHIP SERIES. THESE BRING NATIONALLY RECOGNIZED CHILDHOOD CANCER EXPERTS TO MINNESOTA TO SPEAK ON CURRENT SURVIVORSHIP, CLINICAL AND RESEARCH ISSUES, AS WELL AS BUILD NEW RESEARCH COLLABORATIONS. 364641 FAMILY SUPPORT PROGRAMS:OUR DEDICATED FAMILY PROGRAMS IMPROVE THE WELL-BEING OF KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCES OF CANCER TREATMENT, SURVIVORSHIP, OR BEREAVEMENT. THESE OFFERINGS INCLUDE: - THE BIG DREAMS TOUR - A CREATIVE OUTLET THAT REDUCES ISOLATION BY LEVERAGING AR, VR, AND XR TECHNOLOGY TO PROVIDE PEDIATRIC CANCER PATIENTS AN OPPORTUNITY TO GAME TOGETHER MONTHLY AND CREATE THEIR OWN ANIMATED MUSIC VIDEO, VIDEO GAME, OR VFX VIDEO; INCLUDING COMMUNITY EVENTS WHERE THEIR CREATIONS ARE BROUGHT TO LIFE IN TEXAS, VIRGINIA, MAINE AND MINNESOTA. - CAMP NORDEN - IN-PERSON AND VIRTUAL FIVE-DAY SUMMER CAMPS ARE DESIGNED ESPECIALLY TO MEET THE UNIQUE NEEDS OF CHILDREN WHO HAVE BEEN DIAGNOSED WITH CANCER AND SUPPORT FRIENDSHIP-BUILDING, SOLIDARITY WITH PEERS, INCREASED SELF-ESTEEM, AND A FEELING OF INDEPENDENCE. THESE CAMPS FOSTER COMMUNITY AND ELIMINATE FINANCIAL OR GEOGRAPHICAL BARRIERS TO ATTEND. -CC BEAR- OUR CURE CANCER "C.C." BEAR IS READY TO COMFORT AND CARE FOR THOSE WHO NEED HIM MOST AT NO COST TO FAMILIES. 358 BEARS WERE SENT TO CHILDREN WITH CANCER, AND THEIR SIBLINGS. 5510067 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 15 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MN AL AR CA CT FL GA HI IL KS KY MA MD MI MA NC NH NJ NM NY OK OR PA RI SC TN UT VA WI WV X X THE ORGANIZATION 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 X X ELIZABETH ALLEN CHIEF EXECUTIVE OFFICER 40.00 X X 0 0 0 ABBIE MILLER MD CHAIRPERSON 1.00 X X 0 0 0 CHRIS ZUPFER VICE CHAIR 1.00 X X 0 0 0 MEGHAN HARRIS SECRETARY 1.00 X X 0 0 0 JEN WILSON TREASURER 1.00 X X 0 0 0 CHARLIE ANDERSON DIRECTOR 1.00 X 0 0 0 ADAM CHOE DIRECTOR THROUGH MAY 1.00 X 0 0 0 HEIKE DRAKE-CAVALLETTI DIRECTOR 1.00 X 0 0 0 BARB FARRELL DIRECTOR 1.00 X 0 0 0 MEGAN GOODRICH DIRECTOR 1.00 X 0 0 0 PATRICIA GRAY DIRECTOR 1.00 X 0 0 0 MICHAEL HARRIS DIRECTOR 1.00 X 0 0 0 DAWN LAMM DIRECTOR 1.00 X 0 0 0 ASHLEY THRONSON DIRECTOR 1.00 X 0 0 0 CHRIS TOPPIN DIRECTOR 1.00 X 0 0 0 JENNIFER VALL DIRECTOR 1.00 X 0 0 0 0 0 0 2 417535 2895245 230753 3312780 91882 91882 5083533 3822925 1260608 1260608 1260608 42135 417535 259002 -216867 -216867 OTHER INCOME 900099 22004 22004 22004 4470407 22004 0 1135623 2971846 2971846 141976 68623 39707 33646 1737754 839931 486010 411813 60987 29477 17057 14453 181504 87729 50762 43013 151044 73006 42244 35794 24546 21087 880 2579 46000 39519 1648 4833 5520 5520 425663 365687 15252 44724 378614 203189 175425 577651 432256 3540 141855 193602 85287 58634 49681 128816 65102 34489 29225 28662 14485 7675 6502 112259 56733 30058 25468 8709 4401 2332 1976 VENUE AND ENTERTAINMENT 160514 75130 2419 82965 FEES, LICENSES AND PERM 135903 60298 20551 55054 TRAINING AND DEVELOPMEN 33685 16281 9421 7983 OTHER DIRECT FUNDRAISIN -259002 -259002 7246253 5510067 828199 907987 X 576445 385827 0 190618 7444970 2781737 2570318 249455 1028868 743739 0 25000 193598 785665 1107720 776858 365804 330862 4884022 5343047 1050510 983460 17538090 11242965 1180441 1367438 7629529 5223499 1194056 1127210 10004026 7718147 X 4336541 462917 3197523 3061901 7534064 3524818 17538090 11242965 -2775846 -1233400 0 X X 0 1 X 1 0 X 21100949 18617613 17954505 18237103 3312780 79222950 21100949 18617613 17954505 18237103 3312780 79222950 1598008 77624942 97784 97890 172078 233878 91882 693512 40171 69543 42294 42454 22004 216466 80132928 1483667 0.96870 0.98010 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2021 AMOUNT: $ 40,171. 2022 AMOUNT: $ 69,543. 2023 AMOUNT: $ 42,294. 2024 AMOUNT: $ 42,454. 2025 AMOUNT: $ 22,004. SCHEDULE A, PART II THE ORGANIZATION HAD A CHANGE IN ACCOUNTING PERIOD AND IS FILING A SHORT YEAR RETURN FOR THE PERIOD 1/1/2025 TO 6/30/2025. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 973881 40622 1014503 884407 139474 50000 973881 739333 145074 884407 889385 -150052 739333 745506 143879 889385 0.00000 0.52522 0.47478 0 0 1107720 776858 330862 330862 OPERATING LEASE RIGHT-OF-USE 983460 983460 OPERATING LEASE OBLIGATION 1127210 1127210 X 11580803 -1233400 8090314 6856914 4723889 5520 -259002 -253482 4470407 15590049 8090314 259002 8349316 7240733 5520 5520 7246253 PART V, LINE 4: THE PURPOSE OF THE ENDOWMENT FUNDS IS TO PROVIDE SUPPORT TO HELP ERADICATE CHILDHOOD CANCER. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THEREFORE, THE STATEMENTS DO NOT INCLUDE A PROVISION FOR INCOME TAXES BUT IS SUBJECT TO INCOME TAX ON NET UNRELATED BUSINESS INCOME. THE ORGANIZATION REVIEWS INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN INCOME TAX RETURNS TO DETERMINE IF THERE ARE ANY INCOME TAX UNCERTAINTIES. THIS INCLUDES POSITIONS THAT THE ENTITY IS EXEMPT FROM INCOME TAXES OR NOT SUBJECT TO INCOME TAXES ON UNRELATED BUSINESS INCOME. THE ORGANIZATION RECOGNIZES TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE ORGANIZATION HAS IDENTIFIED NO INCOME TAX UNCERTAINTIES. THE ORGANIZATION FILES INFORMATION RETURNS AS A TAX-EXEMPT ORGANIZATION. SHOULD THAT STATUS BE CHALLENGED IN THE FUTURE, ALL YEARS SINCE INCEPTION COULD BE SUBJECT TO REVIEW BY THE IRS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES -259,002. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 259,002. AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DAWN OF A DREAM 459670 417535 42135 39288 21625 6500 61424 8299 121866 459670 417535 42135 39288 21625 6500 61424 8299 121866 259002 -216867 1 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)(3) 579550 0 TO UNIVERSITY OF MINNESOTA FOR DR. JOHN WAGNER'S RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)(3) 187799 0 DR. OLIN'S BRAIN TUMOR RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)(3) 1575000 0 DEPT OF PEDIATRICS FELLOWSHIPS AND SEED GRANTS CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE 2716 SOUTH STREET PHILADELPHIA PA 19104 231352166 501(C)(3) 250000 0 DR. MATTHEW HOCKING FOR PEDIATRIC CANCER RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 746001118 501(C)(3) 250000 0 DR. MICHAEL ANDREEFF FOR PEDIATRIC CANCER RESERACH LAD IN A BATTLE LLC 109 WOODBRIDGE ROAD YORK ME 03909 472959863 150000 0 BIG DREAMS TOUR - JAMES ORRIGO LAD IN A BATTLE LLC 109 WOODBRIDGE ROAD YORK ME 03909 472959863 25000 0 FOR VIRTUAL CAMP NORDEN FOR PEDIATRIC CANCER PATIENTS 3 1 PART I, LINE 2: THE ORGANIZATION PROVIDES FUNDS TO THE UNIVERSITY OF MINNESOTA AND OTHER RESEARCH HOSPITALS FOR RESEARCH AND TRAINING RELATING TO THE PREVENTION, TREATMENT AND CURE OF CHILDHOOD CANCER. THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE MONITOR THE USE OF GRANT FUNDS. X 9 230753 US STOCK EXCHANGE 0 0 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: CCRF HAS AN EXECUTIVE COMMITTEE WHICH CONSISTS OF THE CHAIRPERSON, THE VICE CHAIRPERSON, THE VICE CHAIRPERSON ELECT, THE TREASURER, AND THE SECRETARY. THE CHAIRPERSON MAY ALSO APPOINT SUCH OTHER MEMBERS OF THE BOARD OF DIRECTORS TO THE EXECUTIVE COMMITTEE AS HE OR SHE DETERMINES APPROPRIATE. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWERS TO ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS DURING THE PERIODS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS TO TAKE ANY ACT THAT MAY BE TAKEN BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL MEET AT REGULAR INTERVALS THROUGHOUT THE YEAR. THE CEO SHALL ATTEND THE MEETINGS OF THE EXECUTIVE COMMITTEE AS A NONVOTING PARTICIPANT. THE CORPORATION MAY EXCLUDE THE CEO FROM MEETINGS OF THE EXECUTIVE COMMITTEE OR ANY PORTION OF A MEETING OR FROM ACCESS TO RELATED MATERIALS. IN THE ABSENCE OF A NOMINATING COMMITTEE, THE EXECUTIVE COMMITTEE SHALL FULFILL THE PURPOSES OF THE NOMINATING COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE, INVESTMENT & ADMINISTRATION COMMITTEE REVIEWS THE FORM 990 AND RECOMMENDS ITS APPROVAL TO THE EXECUTIVE COMMITTEE. THE BOARD OF DIRECTORS RECEIVES A COPY OF THE 990 FORM BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL BOARD OF DIRECTORS AND EMPLOYEES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND SIGN AN ANNUAL DISCLOSURE STATEMENT. ALL FINANCIAL TRANSACTIONS AND CONTRACTS ARE REVIEWED BY THE DIRECTOR OF FINANCE AND, IF NECESSARY, THE CEO AND ATTORNEYS TO ENSURE NO TRANSACTIONS ARE EXECUTED THAT COULD BE INTERPRETED AS INTRODUCING A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ANNUALLY, THE EXECUTIVE COMMITTEE REVIEWS THE CEO'S COMPENSATION AND RECOMMENDS A SPECIFIC LEVEL OF COMPENSATION. A COMPREHENSIVE COMPENSATION STUDY FOR ALL ORGANIZATIONAL POSITIONS IS PERFORMED PERIODICALLY, WHICH COMPARES SALARIES FOR EACH JOB DESCRIPTION RELATIVE TO GEOGRAPHIC LOCATION, ORGANIZATIONAL SIZE AND TYPE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC ON OUR WEBSITE. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY CAN ALSO BE PROVIDED UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A: THE ORGANIZATION HAD A CHANGE IN ACCOUNTING PERIOD AND IS FILING A SHORT YEAR RETURN FOR THE PERIOD 1/1/2025 TO 6/30/2025. THE ORGANIZATION HAS PAID EMPLOYEES. PER IRS INSTRUCTIONS, NO CALENDAR YEAR COMPENSATION IS BEING REPORTED ON THIS SHORT PERIOD RETURN DUE TO NO CALENDAR YEAR ENDING WITHIN THE SHORT YEAR PERIOD. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.